miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes

  • Authors:
    • Weidong Chen
    • Zhaoqing Tang
    • Yihong Sun
    • Youyou Zhang
    • Xuefei Wang
    • Zhenbin Shen
    • Fenglin Liu
    • Xinyu Qin
  • View Affiliations

  • Published online on: December 6, 2011     https://doi.org/10.3892/etm.2011.411
  • Pages: 351-356
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of this study was to identify and evaluate microRNAs (miRNAs) in gastric cancer lymph node metastasis. A miRNA array was used to compare the expression of miRNAs in primary gastric cancer and paired lymph node metastases. miRNAs found to be differentially expressed were validated in a cohort of primary gastric cancer tissues, and the relationship between expression and the clinicopathological characteristics of the specimens was analyzed. The expression level of miR-10a in a gastric mucosal cell line and three gastric cancer cell lines was also detected using qPCR. Moreover, the target genes for miR-10a were predicted using bioinformatic methods. Based on the results, four differentially expressed miRNAs were detected by the miRNA array. Compared with primary gastric cancer, lymph node metastases displayed downregulated expression of miR-24-1*, miR-510 and miR-1284, while the expression of miR-10a was upregulated. Consequently, analysis found that the expression of miR-10a was associated with lymph node metastasis (P=0.047), but was independent of the state of lymphatic invasion (P=0.169) in the cohort of primary gastric carcinoma. The expression of miR-10a was at least 10-fold higher in the three gastric cancer cell lines than in the gastric mucosal cell line. Two gastric cancer cell lines, which were established from lymph node metastasis, expressed higher miR-10a compared to the primary tumor origin cell line. Bioinformatic analysis demonstrated that the target genes of miR-10a are involved in multiple related pathways of tumorigenesis and metastasis. In conclusion, our study suggests that miR-10a is involved in the development of gastric cancer and lymph node metastasis, particularly in the latter process.

Introduction

Gastric cancer is one of the most common malignant tumors of the digestive system, and its early diagnosis rate is still low in China, where gastric cancer is typically diagnosed at a more advanced stage; metastasis is typically present at the time of diagnosis. However, conventional strategies based on radical surgery for the treatment of gastric cancer are not yet satisfactory. Therefore, investigation of the mechanisms of metastasis and recurrence of gastric cancer, and exploration of the methods for the effective prediction, prevention and treatment of tumor metastasis are attracting increased attention in both basic and clinical cancer research.

microRNAs (miRNAs), discovered in 1993, are a class of non-coding RNAs 19–25 nt in length that regulate gene expression at the post-transcriptional level (1,2). These miRNAs regulate complicated cellular processes such as differentiation, proliferation and apoptosis (3) and are widely involved in tumorigenesis, tumor progression and metastasis (4,5). Recent research suggests that miRNAs are involved in tumor invasion and metastasis, in the context of breast cancer, colorectal cancer, esophageal squamous cell carcinoma, and pancreatic endocrine tumors (6,7). Few studies have reported the role of miRNAs in gastric cancer owing to its relatively low incidence in Europe and America. Therefore, profiling should be performed in different types of gastric cancer to identify differentially expressed miRNAs. In the present study, we investigated differences in miRNA profiling between primary gastric cancer and paired lymph node metastasis, and then detected the differentially expressed miRNAs in 4 cell lines, 33 gastric cancer specimens and corresponding adjacent gastric mucosa tissue, in an effort to identify the miRNAs involved in gastric cancer lymph node metastasis. Furthermore, our data provide evidence regarding the effects of miRNAs on metastasis involved in the molecular pathogenesis of gastric cancer.

Materials and methods

Specimens
Specimens used in the miRNA array

Cases of full-thickness gastric wall with invasion and lymph nodes with tumor metastasis were assessed intraoperatively; specimens from the primary tumor were retained. The specimens were embedded in optimal cutting temperature compound (OCT) and stored at −80°C until use. Experimental samples were selected to pathologically confirm that invasive adenocarcinoma of the stomach lesions was of full thickness and to verify the existence of lymph node metastasis. In total, 5 pairs of specimens (each of which included primary tumor and paired lymph node metastasis tissues) were selected, and their clinicopathological characteristics are summarized in Table I.

Table I.

Data from the gastric cancer patients.

Table I.

Data from the gastric cancer patients.

No.GenderAgeTumor locationType DifferentiationTaNaOthers
1Male67Lower 1/3AdenocarcinomaII33Lymphatic invasion
2Male54Mid 1/3AdenocarcinomaII–III31Lymphatic invasion
3Male62Lower 1/3AdenocarcinomaII32Unknown
4Male52Lower 1/3AdenocarcinomaIII31Neural invasion
5Male76Lower 1/3AdenocarcinomaIII33Neural invasion

a According to the American Joint Committee on Cancer (AJCC) TNM staging classification for carcinoma of the stomach (7th edition).

Specimens used for validation

Surgical specimens were obtained from 33 randomly selected patients with primary tumors among those who underwent D2 radical resection of gastric cancer at ZhongShan Hospital, Fudan University (Shanghai, China) from May, 2006 to December, 2007. All eligible cases had not received preoperative tumor-related treatment, were pathologically confirmed as gastric adenocarcinoma, and displayed full-thickness gastric wall invasion. Clinicopathological statistical data are shown in Table IV. Another 10 cases were randomly selected from the 33 cases mentioned above; normal gastric mucosa tissues were taken from the tumor marginal zone (>5 cm from the tumor). These samples were mixed in proper proportion after RNA extraction and used as the control group (indicated below with an N). Random sampling was performed with SPSS software. Ethical approval was obtained from the ZhongShan Hospital Research Ethics Committee.

Table IV.

Clinicopathological characteristics of the 33 cases of gastric cancer.

Table IV.

Clinicopathological characteristics of the 33 cases of gastric cancer.

P-value
VariableCases, n (%)miR-10amiR-510
Gender0.8610.918
  Male28 (84.8)
  Female5 (15.2)
Age (year)0.8740.280
  <609 (27.3)
  ≥6024 (72.7)
Types0.9780.691
  Adenocarcinoma23 (69.7)
  Tubular adenocarcinoma8 (24.2)
  Signet ring cell carcinoma2 (6.1)
Differentiation0.9790.897
  Moderately differentiated (II)10 (30.3)
  Poorly differentiated (III)21 (63.6)
  No differentiation (IV)2 (6.1)
Lymphatic invasion0.1690.365
  Yes18 (54.4)
  No15 (45.5)
Lymph node metastasis0.0470.204
  Yes13 (39.4)
  No20 (60.6)
Gastric cancer cell lines

Human gastric cancer cell lines, AGS and SGC7901, were purchased from the Cell Bank of the Chinese Academy of Sciences. The human gastric mucosal cell line GES-1 and moderately differentiated tubular adenocarcinoma cell line MKN-28 were a gift from the Institute of Digestive Disease, Shanghai Jiaotong University. All cells mentioned above were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum in 5% CO2 at 37°C.

Methods
Laser capture microdissection (LCM)

The collected tissues embedded in OCT were cut in 8-μm sections at −20°C, after being stained with hematoxylin and eosin (H&E). The stained slides were placed into a Veritas Microdissection Instrument (Veritas, Mountain View, CA). Areas that were enriched in tumor cells (10 mm2/slides) were selected and captured using ultraviolet laser cutting according to the manufacturer’s recommended protocol. The tissue samples were immediately placed in a microcentrifuge tube containing lysis/binding buffer (Ambion, Inc., USA), which was vortex-mixed and stored upside down at −20°C. RNA concentration and integrity were determined by UV absorption and agarose gel electrophoresis, respectively.

miRNA array

miRCURY LNA™ microRNA arrays (Agilent Technologies, Santa Clara, CA), which contain more than 1,700 capture probes, were used to compare the expression profiles of 5 paired primary gastric cancer tissues and metastatic lymph nodes collected from the same case. A difference in expression was defined as a change of >1.5-fold in the corresponding level of miRNA detection between paired specimens. The Student’s t-test was used to analyze whether there were significant differences between paired samples.

qPCR assessment of miRNA (8)

miRNA genes were selected from the Sanger Center miRNA Registry (http://www.mirbase.org). The sequence-specific primers for miRNAs and endogenous control U6 snRNA were synthesized by Sangon (Shanghai, China) (Table II). The reverse-transcription reaction was carried out with miRNA-specific stem-loop RT primer and reverse transcriptase (Fermantas, USA) according to the manufacturer’s instructions. Real-time quantification polymerase chain reaction (qPCR) analysis was carried out after cDNA was synthesized. Reaction conditions were as follows: 95°C for 10 min; followed by 40 cycles of 95°C for 15 sec, 60°C for 15 sec, and 72°C for 45 sec for the amplification. The threshold cycle (Ct) is defined as the fractional cycle number at which the fluorescence passes the fixed threshold. The gene expression Ct values of miRNAs from each sample were calculated by normalization to the internal control U6 snRNA. All experiments were repeated in triplicate.

Table II.

Primer sequences used for miRNA expression analysis with gene name, sequence (5′-3′).

Table II.

Primer sequences used for miRNA expression analysis with gene name, sequence (5′-3′).

Primer namePrimer sequence
miR-510-RT 5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACGTGATT-3′
miR-10a-RT 5′-GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACCACAAA-3′
U6-RT 5′-CGCTTCACGAATTTGCGTGTCAT-3′
U6-F 5′-GCTTCGGCAGCACATATACTAAAAT-3′
U6-R 5′-CGCTTCACGAATTTGCGTGTCAT-3′
miR-510-F 5′-TACTCAGGAGAGTGGCAATCA-3′
miR-10a-F 5′-TACCCTGTAGATCCGAATTTG-3′
Universal reverse primer 5′-GTGCAGGGTCCGAGGT-3′

[i] F, forward primer; R, reverse primer; RT, reverse transcription primer.

Bioinformatic analysis of miRNA

miRGen (http://www.diana.pcbi.upenn.edu/miRGen/v3/miRGen.html) was employed for the prediction of miR-10a target genes. Functional analysis of the predicted targets was performed using MAS3.0 Bioinformatics Resources (http://bioinfo.capitalbio.com/mas3/).

Statistical analysis

miRNA expression in tumor samples was detected by real-time quantitative PCR and then subjected to N normalization. The relationship between changes in miRNA expression and clinicopathologic characteristics was analyzed using one-way ANOVA. Two-tailed P<0.05 was judged to be significant. All data and statistics processing were performed with Excel 2007 (Microsoft, USA) and SPSS 16.0 (SPSS, Chicago, IL).

Results

Results of the miRNA array

Considering the expression level of miRNAs in primary gastric cancer as baseline, there were 76 upregulated and 106 downregulated miRNAs associated with lymph node metastasis, among which four statistically significant miRNAs were included: three downregulated (miR-24-1*, miR-510 and miR-1284) and one upregulated miRNA (miR-10a) (Table III).

Table III.

Differentially expressed miRNAs detected by miRNA array.

Table III.

Differentially expressed miRNAs detected by miRNA array.

Fold changeP-valueNormalization
miRNALN/TLN/TTLN
hsa-miR-24-1*0.48310.04010.0710.0343
hsa-miR-5100.39990.00690.08280.0331
hsa-miR-12840.57160.00990.23660.1352
hsa-miR-10a2.39290.02030.04010.096

[i] LN, lymph node metastasis tissue; T, tumor tissue.

Differentially expressed miRNAs in primary gastric tumors

We examined the two most obviously changed miRNAs (miR-10a and miR-510) in 33 cases of primary gastric cancer and corresponding normal tissue (N). Each detected miRNA exhibited a good amplification curve; the melting curve had a single peak. The results suggested that the products of the real-time PCR were specific, and the experimental results were reliable.

Expression levels of miR-10a and miR-510 were measured in 33 cases of primary gastric cancer and its corresponding normal tissue. The average ΔCt (9) values of the tumor tissue were 12.48±1.91 and 12.78±1.76, respectively. The average ΔCt values of the corresponding adjacent normal tissue were 14.52±0.60 and 13.11±0.80, respectively. The expression of miR-10a was higher in gastric cancer than that in the adjacent normal mucosa (P<0.05) (Fig. 1).

Clinicopathologic characteristics

We investigated the relationship between expression of miR-10a and miR-510 and each of six clinicopathological characteristics (patient age, gender, tumor differentiation, major tumor histological classification, lymphatic invasion and lymph node metastasis). The results showed that only miR-10a expression was significantly related to node metastasis (P=0.047); this measure was not related to the state of lymphatic invasion (P=0.169) (Fig. 2 and Table IV).

Expression of miR-10a in the cell lines

The expression of miR-10a varied in all four cell lines. The expression of miR-10a in the MKN28, SGC7901 and AGS cell lines was 15-fold, 11.7-fold and 10.1-fold higher than that in the GES-1 cell line (Fig. 3). As MKN28 and SGC7901 were established from lymph node metastasis, the expression of miR-10a was higher in these two metastasis original cell lines than that in the AGS cell line which was established from a primary tumor.

Bioinformatic analysis of target genes for miR-10a

Potential target genes of miR-10a were predicted using miRGen; the corresponding results from the PicTar and TargetScanS databases were chosen as candidate targets; 118 potential target genes were obtained. KEGG analysis showed that the predicted target genes involved many signal pathways involved in tumorigenesis and tumor metastasis, such as the Wnt signal pathway and that initiated by cell adhesion molecules (CAMs) (Table V).

Table V.

The most significant 5 pathways identified in the functional analysis of the miR-10a target genes.

Table V.

The most significant 5 pathways identified in the functional analysis of the miR-10a target genes.

PathwayGeneP-value
Wnt signaling pathwayBTRC, NFAT5, DVL3, CTNNBIP1, CAMK2G0.000013
ErbB signaling pathwaySHC1, CRK, CAMK2G0.00069
Focal adhesionSHC1, ACTG1, CRK, FLT10.00074
Cell adhesion moleculesNFASC, SDC1, CADM10.0024
Notch signaling pathwayNCOR2, DVL30.0039

Discussion

Few research efforts to date have examined the lymph node metastasis of gastric cancer using high-throughput methods (10,11). These publications have focused mainly on the genomic and proteomic differences between primary gastric cancer patients with metastasis and those without metastasis. Samples taken from different parts of the same person may help to avoid false-positive results on the miRNA array (caused by background differences among genes). In order to improve the specificity of the chip-based results, we chose to investigate primary gastric cancer and paired lymph node metastasis sites in the same patient. As the ratio of lymph node metastasis increases with the increased depth of invasion (12,13), the specimens selected in the study all displayed full-thickness invasion.

The results obtained identified four differentially expressed miRNAs. miR-10a was upregulated while miR-24-1*, miR-510 and miR-1284 were downregulated in lymph node metastatic sites as compared to the primary gastric cancer. We hypothesized that if some relationship exists between the level of miRNA expression in the primary tumor sites and metastasis, it is quite possible that miRNAs contribute to the process of gastric cancer lymph node metastasis and may have the ability to serve as indicators in lymph node metastasis detection. In order to prove the hypothesis, we investigated the expression level of miR-10a and miR-510, which were the most obviously changed in the miRNA array, in the gastric cancer primary sites of 33 patients. The results showed that the expression level of miR-10a was affected by the existence of lymphatic metastasis, while there was no obvious relationship with the state of lymphatic invasion. Furthermore, miR-10a was upregulated in gastric cancer at both the tissue and cell levels; more obvious differences were noted at the cell level. Noticeably, the expression of miR-10a in the two metastasis original cell lines (MKN28 and SGC7910) was higher than that of the AGS cell line which was established from a primary tumor. This find also indicated that miR-10a was closely associated with lymph node metastasis. To assess the possibility of using miR-10a as a biomarker in lymph node metastasis, further research with more samples is needed.

miR-10a belongs to the miR-10 family; the other member is miR-10b. These two members differ from each other in only one base. Recently, several reports found that miR-10 expression was aberrantly increased in several types of cancers (1417), upregulated in glioma, liver cancer, colon cancer, melanoma and breast cancer; downregulated in acute or chronic lymphocytic leukemia and head and neck squamous-cell carcinoma. However, studies concerning the function of miR-10 are still lacking. Fortunately, miR-10 was proven to play a pivotal role in tumor invasion and metastasis in these studies. Ma et al (18) found that miR-10b was significantly correlated with breast tumor cell metastasis. They also demonstrated the ability of grafted tumors in mice to invade locally and transfer to distant sites and this was associated with upregulated expression of miR-10b in breast cancer cells lacking metastatic ability. In subsequent studies, the group effectively inhibited the distant metastasis of grafted mouse tumors using miR-10b antagomirs (chemically modified anti-miRNA oligonucleotides) (19). These results stimulated related research. Weiss et al (20) found that miR-10a was highly expressed in pancreatic cancer cell lines with high metastatic ability. Experimental manipulation of miR-10a expression altered the ability of pancreatic cancer cells to metastasize and invade. This pattern was also observed in zebrafish transplanted with pancreatic cancer. In gastric cancer, research on miR-10 is still limited to describing changes in miR-10 expression, with no elucidation of the detailed mechanisms. Li et al (21) found a seven-miRNA signature in gastric cancer (including miR-10b), which had a close relationship with disease-free survival and overall survival rate. Another study excluded a role for miR-10 family members (22). Although there is no report on whether miR-10 contributes to the mechanism of gastric cancer metastasis, the relationship of miR-10a to gastric cancer lymph node metastasis demonstrated in our research provides promising evidence for subsequent research.

miRNAs function post-transcriptionally during biological processes; therefore, definitive identification of miRNA target genes is essential. For this reason, we used bioinformatic methods to predict miR-10a target genes, and then analyzed the possible mechanisms of its role in gastric tumorigenesis and metastasis. We chose the most commonly used target gene-predicting databases, PicTar (23) and TargetScanS (24), which are available on the miRGen website (25). To narrow the scope of this hunt for target genes and improve the specificity of the prediction, we chose the results common to both databases and subjected these to functional analysis. The analysis of KEGG (26) metabolic pathways showed that these predicted targets took part in many pathways involved in tumorigenesis, invasion and metastasis. For example, the Wnt signaling pathway plays an important role in organism development and gastrointestinal tumorigenesis (27), and cell adhesion molecules (CAMs) localized at the cell surface take part in intercellular and extracellular interactions.

These findings strongly suggest that miR-10a is closely correlated with gastric tumorigenesis and metastasis. A possible mechanism may be that it functions through interaction with target genes involved in tumorigenesis- and metastasis-related pathways.

Acknowledgements

This study is supported by the Key Project of the Chinese Ministry of Education (no. 108015). We thank other members of our department for their valuable comments and help.

References

1. 

B WightmanI HaG RuvkunPosttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegansCell75855862199310.1016/0092-8674(93)90530-48252622

2. 

RC LeeRL FeinbaumV AmbrosThe C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14Cell758438541993

3. 

DP BartelMicroRNAs: genomics, biogenesis, mechanism, and functionCell116281297200410.1016/S0092-8674(04)00045-514744438

4. 

GA CalinCM CroceMicroRNA signatures in human cancersNat Rev Cancer6857866200610.1038/nrc199717060945

5. 

A Esquela-KerscherFJ SlackOncomirs-microRNAs with a role in cancerNat Rev Cancer6259269200610.1038/nrc1840

6. 

Q HuangK GumireddyM SchrierThe microRNAs miR-373 and miR-520c promote tumor invasion and metastasisNat Cell Biol10202210200810.1038/ncb168118193036

7. 

L MaRA WeinbergMicroRNAs in malignant progressionCell Cycle7570572200810.4161/cc.7.5.5547

8. 

C ChenDA RidzonAJ BroomerReal-time quantification of microRNAs by stem-loop RT-PCRNucleic Acids Res33e179200510.1093/nar/gni17816314309

9. 

KJ LivakTD SchmittgenAnalysis of relative gene expression data using real-time quantitative PCR and the 2[−Delta Delta C(T)] methodMethods254024082001

10. 

L WangJS ZhuMQ SongComparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarrayWorld J Gastroenterol12694969542006

11. 

M MoriK MimoriY YoshikawaAnalysis of the gene-expression profile regarding the progression of human gastric carcinomaSurgery131Suppl 1S39S47200210.1067/msy.2002.11929211821786

12. 

T UshijimaM SasakoFocus on gastric cancerCancer Cell5121125200410.1016/S1535-6108(04)00033-9

13. 

LF Onate-OcanaV Aiello-CrocifoglioR Mondragon-SanchezSurvival benefit of D2 lympadenectomy in patients with gastric adenocarcinomaAnn Surg Oncol7210217200010.1007/BF0252365610791852

14. 

X AgirreA Jimenez-VelascoE San Jose-EnerizDown-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increase USF2-mediated cell growthMol Cancer Res618301840200810.1158/1541-7786.MCR-08-016719074828

15. 

L ZhangJ HuangN YangMicroRNAs exhibit high frequency genomic alterations in human cancerProc Natl Acad Sci USA10391369141200610.1073/pnas.050888910316754881

16. 

M Jongen-LavrencicSM SunMK DijkstraMicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemiaBlood11150785085200810.1182/blood-2008-01-13335518337557

17. 

H VarnholtU DrebberF SchulzeMicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinomaHepatology4712231232200810.1002/hep.2215818307259

18. 

L MaJ Teruya-FeldsteinRA WeinbergTumor invasion and metastasis initiated by microRNA-10b in breast cancerNature449682688200710.1038/nature0617417898713

19. 

L MaF ReinhardtRA WeinbergTherapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor modelNat Biotechnol28341347201010.1038/nbt.161820351690

20. 

FU WeissIJ MarguesJM WolteringRetinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancerGastroenterology13721362145200910.1053/j.gastro.2009.08.06519747919

21. 

X LiY ZhangD FanSurvival prediction of gastric cancer by a seven-microRNA signatureGut59579585201010.1136/gut.2008.17549719951901

22. 

T UedaS VoliniaH OkumuraRelation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysisLancet Oncol11136146201010.1016/S1470-2045(09)70343-220022810

23. 

A KrekD GrunMN PoyCombinatorial microRNA target predictionsNat Genet37495500200510.1038/ng1536

24. 

BP LewisCB BurgeDP BartelConserved seed pairing, often flanked by adenosines indicates that thousands of human genes are microRNA targetsCell1201520200510.1016/j.cell.2004.12.03515652477

25. 

M MegrawP SethupathyB CordamiRGen: a database for the study of animal microRNA genomic organization and functionNucleic Acids Res35D149D155200710.1093/nar/gkl90417108354

26. 

M KanehisaS GotoKEGG: Kyoto encyclopedia of genes and genomesNucleic Acids Res282730200010.1093/nar/28.1.2710592173

27. 

P PolakisWnt signaling and cancerGenes Dev14183718512000

Related Articles

Journal Cover

February 2012
Volume 3 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen W, Tang Z, Sun Y, Zhang Y, Wang X, Shen Z, Liu F and Qin X: miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes. Exp Ther Med 3: 351-356, 2012
APA
Chen, W., Tang, Z., Sun, Y., Zhang, Y., Wang, X., Shen, Z. ... Qin, X. (2012). miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes. Experimental and Therapeutic Medicine, 3, 351-356. https://doi.org/10.3892/etm.2011.411
MLA
Chen, W., Tang, Z., Sun, Y., Zhang, Y., Wang, X., Shen, Z., Liu, F., Qin, X."miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes". Experimental and Therapeutic Medicine 3.2 (2012): 351-356.
Chicago
Chen, W., Tang, Z., Sun, Y., Zhang, Y., Wang, X., Shen, Z., Liu, F., Qin, X."miRNA expression profile in primary gastric cancers and paired lymph node metastases indicates that miR-10a plays a role in metastasis from primary gastric cancer to lymph nodes". Experimental and Therapeutic Medicine 3, no. 2 (2012): 351-356. https://doi.org/10.3892/etm.2011.411